Jay S Skyler Selected Research

Exubera

11/2008	Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
3/2007	Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jay S Skyler Research Topics

Disease

68	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2024 - 01/2004
10	Insulin Resistance 01/2023 - 01/2009
9	Hypoglycemia (Reactive Hypoglycemia) 02/2024 - 01/2004
8	Type 2 Diabetes Mellitus (MODY) 01/2024 - 09/2002
5	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 12/2021 - 12/2018
5	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 07/2011
5	Infections 01/2019 - 11/2009
3	Chronic Renal Insufficiency 01/2024 - 01/2021
3	Glucose Intolerance 01/2023 - 09/2009
2	Body Weight (Weight, Body) 01/2024 - 06/2019
2	Hyperglycemia 06/2019 - 03/2008
2	Disease Progression 01/2019 - 06/2013
2	Neutropenia 07/2011 - 11/2009
2	Inflammation (Inflammations) 01/2009 - 01/2004
2	Obesity 01/2009 - 09/2002
1	Kidney Diseases (Kidney Disease) 01/2024
1	Renal Insufficiency (Renal Failure) 10/2023
1	Heart Failure 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Ketosis 12/2018
1	Dyslipidemias (Dyslipidemia) 07/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 08/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2013
1	Injection Site Reaction 06/2013
1	Rubella (German Measles) 12/2011
1	Diphtheria 12/2011
1	Measles 12/2011
1	Mumps 12/2011
1	Hepatitis 12/2011
1	Tetanus 12/2011
1	Insulinoma 12/2009
1	Neoplasms (Cancer) 08/2009

Drug/Important Bio-Agent (IBA)

33	Insulin (Novolin)FDA Link 01/2023 - 09/2002
28	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 09/2002
24	AutoantibodiesIBA 01/2023 - 01/2007
20	C-PeptideIBA 02/2024 - 01/2004
5	AntigensIBA 01/2023 - 07/2011
4	AntibodiesIBA 01/2016 - 05/2005
4	Class 8 Receptor-Like Protein Tyrosine PhosphatasesIBA 06/2012 - 12/2009
3	Abatacept (Orencia)FDA Link 01/2023 - 07/2011
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2019 - 07/2015
3	Rituximab (Mabthera)FDA Link 02/2014 - 11/2009
2	IncretinsIBA 01/2021 - 08/2013
2	empagliflozinIBA 01/2020 - 12/2018
2	Sodium-Glucose Transport ProteinsIBA 06/2019 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 06/2019 - 04/2014
2	Monoclonal AntibodiesIBA 01/2019 - 02/2014
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2019 - 09/2018
2	Metformin (Glucophage)FDA LinkGeneric 09/2015 - 09/2002
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 09/2011 - 07/2011
2	PowdersIBA 11/2008 - 03/2007
2	Exubera FDA Link 11/2008 - 03/2007
2	Ribosomal DNA (rDNA)IBA 11/2008 - 03/2007
1	LipidsIBA 01/2024
1	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2024
1	Mineralocorticoid Receptor AntagonistsIBA 01/2024
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2024
1	SodiumIBA 01/2024
1	AlbuminsIBA 10/2023
1	finerenoneIBA 10/2023
1	CreatinineIBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	Hormones (Hormone)IBA 09/2021
1	Fc Receptors (Fc Receptor)IBA 01/2019
1	teplizumabIBA 01/2019
1	KetonesIBA 12/2018
1	pegylated granulocyte colony-stimulating factorIBA 09/2018
1	PeripherinsIBA 01/2016
1	AutoantigensIBA 01/2016
1	Recombinant ProteinsIBA 01/2016
1	EpitopesIBA 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2015
1	Ranolazine FDA Link 07/2015
1	CarbohydratesIBA 07/2015
1	Docosahexaenoic AcidsIBA 06/2015
1	CytokinesIBA 06/2015
1	Interleukin-1 (Interleukin 1)IBA 06/2013
1	Immunomodulating AgentsIBA 06/2013
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 06/2013
1	canakinumab FDA Link 06/2013
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2013
1	ZincIBA 06/2012
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 12/2011
1	VaccinesIBA 07/2011
1	Aluminum Hydroxide (Algeldrate)FDA Link 07/2011
1	aluminum sulfate (alum)IBA 07/2011
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2010
1	Daclizumab (Zenapax)FDA Link 04/2010
1	Insulin Glargine (Lantus)FDA Link 08/2009

Therapy/Procedure

21	Therapeutics 02/2024 - 01/2004
5	Glycemic Control 02/2024 - 01/2004
4	Injections 01/2019 - 07/2005
3	Islets of Langerhans Transplantation 02/2024 - 11/2021
2	Immunotherapy 06/2013 - 07/2011
1	Artificial Pancreas 09/2021
1	Precision Medicine 10/2015
1	Carbohydrate Loading Diet 07/2015
1	Withholding Treatment 04/2014
1	Hyperbaric Oxygenation 07/2012
1	Aftercare (After-Treatment) 12/2011